ReviewFrontiers in immunology2025
The FcRn from gene to protein and function: comparison between species.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Human Antibody Isotypes, Subclasses, Allotypes and Fc Biology: Clinical Implications in Infectious Diseases, Autoimmunity, and Cancer.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Antibody Transcytosis and Neutralizing Activity in Respiratory Epithelial Cells.bioRxiv : the preprint server for biology · 2026Article
- Depletion and recovery of IgG following treatment with an anti-FcRn antibody and IdeS in pigtail macaques.Clinical and experimental immunology · 2026Article
- Depletion and recovery of IgG following treatment with Rozanoliximab and Imlifidase in pigtail macaques.bioRxiv : the preprint server for biology · 2025Article
- Passive Immunity Establishment Through Colostral IgG Absorption in Neonatal Ruminants: Foundation for Efficient Ruminant Production.Animals : an open access journal from MDPI · 2025Review
- Purification and Characterization of Immunoglobulin Y (IgY) Targeting Surface Antigen 1 (SAG1) ofAntibodies (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin Fc receptors are crucial molecules in immunological processes that help maintain homeostasis following internal or external stimuli. Most of the specific gamma recognition molecules (FcγRI, II, and III) are known for their roles in phagocytosis and cellular cytotoxicity against various pathogens and transformed cells and in regulating the humoral immune response. Within this family of IgG Fc receptors, there is a structurally similar receptor with different functions: the so-called neonatal receptor for the Fc fraction of IgG, or FcRn, which is primarily associated with IgG and albumin homeostasis, the transfer of immunity from mother to offspring, and the regulation of the immune response in mammals. Therefore, this molecule could be considered "the regulator and transporter of the main blood proteins" from the blood vessels and the lumen of the mucosa to the tissues of the newborn and neonate, through the epithelium and endothelium. It may act as a trans-tissue and interindividual "protector," as it mediates the transfer of IgG antibodies to the sites where they are needed. Additionally, it regulates plasma albumin and IgG concentrations, contributing to the balance of body fluids. Although there is abundant literature on this receptor, some phenomena remain unexplored or poorly understood. In particular, the variations in its functions across different cell types and between species, how they influence IgG and albumin levels in various body fluids, and the pathways involved in immunity transmission need further investigation. In this paper, we present a comprehensive review of original research articles and analyses focused on the gene, mRNA, and protein composition of the FcRn, with the aim to compare the genetic, structural, and functional characteristics in different mammalian species, focusing on its role in immunity and homeostasis, as well as the ontogeny and phylogeny of the FcRn.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.